Lionheart Health Inc. Newsroom

The inaugural Klotho Conference & Scientific Seminar, held September 15–16 at the UCI Beall Applied Innovation Center, brought together leading researchers, clinicians, and innovators.

Designed to control regenerative protein expressions in vessel walls and surrounding tissues for a wide range of applications.

Innovation leader in healthspan longevity and medical aesthetics with over 500 patent claims to present at Octane Medical Innovation

Lionheart Health, Inc. has announced a special partnership with CoreViva to offer AI enhanced full body MRI to its Lionheart Klotho Wellness Program patients. CoreViva provides arguably the most advanced full body MRI scans with an FDA-cleared AI.

Lionheart Health, Inc., an innovation leader in the development of products for healthspan longevity and medical aesthetics is proud to announce its recognition as a finalist in the category of Best Innovation in Medical Technology Life Sciences in the prestigious High Tech Awards (HTA) organized by Octane, Orange County, CA

– Lionheart Health, Inc., a leading biotech and medical device company focused on healthspan, longevity, and organ regeneration, has been recognized by MedTech Outlook as the Top Implantable Stimulator Developer of the Year.

Lionheart Health, a leader in regenerative health, has been nominated for the Orange County Business Journal's eleventh annual "Innovator of the Year" Awards. This prestigious recognition celebrates individuals and organizations in Orange County demonstrating exceptional brilliance and leadership in innovation.

Lionheart Health, Inc., an Orange County, California- based biotechnology company, has been named one of the 40 semi-finalists advancing in the $101M XPRIZE Healthspan Competition at the Longevity Investors Summit in New York City.

Two innovation leaders team up to launch clinical study aimed to prove improvement in wound healing especially in patients facing limb loss

Leonhardt Ventures LLC is pleased to announce the issuance of U.S. Leonhardt et. al. Patent 12,109,410 with 15 claims entitled “Bioelectric Stimulator”, a significant advancement in the field of regenerative medicine.